Sarepta Therapeutics, Inc.·4

Nov 20, 8:34 PM ET

Ciambrone William 4

4 · Sarepta Therapeutics, Inc. · Filed Nov 20, 2019

Insider Transaction Report

Form 4
Period: 2019-11-18
Transactions
  • Award

    Stock option (right to buy)

    2019-11-18+80,00080,000 total
    Exercise: $97.90Exp: 2029-11-18Common Stock (80,000 underlying)
Footnotes (1)
  • [F1]25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant, in each case, subject to Mr. Ciambrone's continued employment with the Issuer on such vesting dates.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION